CD8A and melanoma: Biopsy of regressing lesions from patients treated with T-VEC had increased MART-1 (melanoma antigen recognized by T-cells 1) specific CD8+ T-cell infiltration and a reduction in the levels of suppressor cells such as CD4+FoxP3+ Treg cells [37].